The Mitochondrial-Derived Peptide MOTS-c: A Player in Exceptional Longevity? — VialBase Research

Summary

This population genetics study identified a MOTS-c variant (m.1382A>C) that is significantly associated with exceptional longevity in Japanese men. This provides the first human population-level evidence linking mitochondrial-derived peptides (MDPs) to lifespan, supporting the concept of MOTS-c as an endogenous longevity factor.

Key Findings

• MOTS-c variant m.1382A>C enriched in Japanese men who reached exceptional longevity (100+)
• This variant was functionally different — the K14Q amino acid change affects MOTS-c activity
• First genetic evidence linking MOTS-c to human lifespan in a population study
• Supports the “mitochondrial theory of aging” through a specific peptide mechanism
• Sex-specific association (men only) suggests hormonal interaction
• MOTS-c levels may decline with age, paralleling other aging biomarkers

Methodology

Population-based genetic association study comparing MOTS-c gene variants in centenarians (n200) versus younger controls (n600) from the Japanese population. Genotyping of mitochondrial DNA variants encoding MOTS-c. Functional characterization of identified variants.

Limitations

• Observational/genetic association — does not prove causation
• Population-specific finding (Japanese) — may not generalize to other ethnicities
• Sex-specific association limits applicability
• Does not establish that exogenous MOTS-c supplementation would confer longevity
• Functional significance of the variant not fully characterized

Relevance to Content

Powerful longevity angle for MOTS-c content. “A genetic variant of MOTS-c is associated with living past 100” is a compelling hook. Important to note this doesn’t prove exogenous MOTS-c extends lifespan, but it establishes MOTS-c as a biologically relevant longevity factor. Essential for positioning MOTS-c in the longevity/anti-aging peptide category.

See Also

• Parent compound: MOTS-c